Becton, Dickinson and Co. | BDX - Net Income

Stock Price
180.96
Daily Change
-1.53 -0.84%
Monthly
-11.04%
Yearly
-20.49%
Q1 Forecast
179.64

Becton, Dickinson and Co. reported $382M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Agilent USD 434M 98M Sep/2025
Align Technology USD 135.76M 79.01M Dec/2025
AngioDynamics USD -4.41M 6.33M Feb/2025
Avanos Medical USD -1.3M 100K Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Bio-Rad Laboratories USD -341.9M 659.7M Sep/2025
Boston Scientific USD 672M 83M Dec/2025
Cooper Companies USD 84.6M 13.7M Sep/2025
Danaher USD 1.2B 289M Dec/2025
Dentsply International USD -427M 382M Sep/2025
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 91.2M 199.9M Dec/2025
Exact Sciences USD -19.59M 18.41M Sep/2025
Globus Medical USD 140.59M 21.63M Dec/2025
Hologic USD 179.1M 8.2M Dec/2025
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -5.4M 478.67M Sep/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
J&J USD 5.12B 36M Dec/2025
Masimo USD -100.4M 151.7M Sep/2025
Medtronic USD 1.14B 231M Dec/2025
Solventum Corp USD 1.27B 1.18B Sep/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -408.89M 531.47M Sep/2025
Terumo JPY 32.65B 2.4B Dec/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025